Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Color Vision and Microperimetry Changes in Nonexudative Age-Related Macular Degeneration After Risuteganib Treatment: Exploratory Endpoints in a Multicenter Phase 2a Double-Masked, Randomized, Sham-Controlled, Crossover Clinical Trial.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: August 11, 2022
The Transcriptome Profile of Retinal Pigment Epithelium and Müller Cell Lines Protected by Risuteganib Against Hydrogen Peroxide Stress.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: June 22, 2022
Impact of Baseline Quantitative OCT Features on Response to Risuteganib for the Treatment of Dry Age-Related Macular Degeneration: The Importance of Outer Retinal Integrity.
Journal: Ophthalmology. Retina
Published: December 28, 2021
Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical Trial.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: June 29, 2021
Risuteganib Protects against Hydroquinone-induced Injury in Human RPE Cells.
Journal: Investigative ophthalmology & visual science
Published: August 21, 2020
Differential effects of risuteganib and bevacizumab on AMD cybrid cells.
Journal: Experimental eye research
Published: June 15, 2020
Showing 1-6 of 6
Last Updated: 09/26/2026